🔗 Share this article

While America continues making historic changes to its vaccination schedules, an unexpected name appears unexpectedly: Høeg, a Danish American sports medicine doctor and public health researcher who initially gained attention by casting doubt on coronavirus vaccinations in the global health crisis and has focused upon potential deaths following COVID-19 vaccination in her brief position at the Food and Drug Administration.

Proposed Shifts to Pediatric Immunization Program

Health officials were set to reveal radical changes to the pediatric vaccination calendar earlier this month, synchronizing the US with the Danish vaccine program, according to reports – a substantial departure that would place the US out of step with many the world with no evidence for public health gain. The announcement has been delayed until the next year.

Rather than the director of the vaccine center, Tracy Beth Høeg is scheduled to speak at the meeting. She was recently named temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to head the office this calendar year.

Consolidating Power at the FDA

The acting appointment might represent a tighter collaboration between the pharmaceutical and vaccine centers as Dr. Høeg and Prasad strengthen their influence at the regulatory agency – and it points to a renewed priority upon dismantling previously authorized immunizations at the FDA.

The new acting director has repeatedly called for discontinuing specific pediatric immunization guidelines in the US to become more similar to the Danish model, a country with comprehensive healthcare and a citizenry roughly the population of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on vaccination policy – typically the purview of Dr. Prasad, chief of the FDA’s vaccine center – instead of medication approval.

Questions Over Expertise

The appointee has no obvious experience in pharmaceutical research, oversight or management, which has been standard for past directors of the biologics center. She has served at the FDA as a top consultant to the FDA chief and the vaccine center since March.

“She appears not to have the necessary background” for running the drug-regulation department, stated a neurologist and psychiatrist. “She’s never run a scientific study. She is not versed in leading a major agency. She has no expertise in industry regulation.”

Previous commissioners of the center would “grasp laws and regulations and the research of pharmaceutical innovation”, said a former acting FDA commissioner. “Frankly, she doesn’t have the type of experience that previous people who headed the center have had.”

The drug center has an immense workload at the agency, the former commissioner emphasized.

“Everybody just focuses on the novel medication approvals, but the generic drug division authorizes numerous off-brand pharmaceuticals. There is also a biosimilars division, OTC medication office and other areas, and all of those must be managed,” Dr. Woodcock explained. “The thing you overlook, that is precisely what that I always told people is going to come back to haunt you.”

Furthermore, a significant administrative element to the job, which manages in excess of 5,000 personnel. “It’s a massive management job, if you execute it properly,” the former official added.

Official Statement and Contentious Initiatives

When asked about questions about Dr. Høeg's credentials and whether this assignment represents greater collaboration among regulatory chiefs on immunizations, a spokesperson said that the “questions stem from incorrect presumptions”.

“Her resume is consistent with the functions of her role,” the representative explained, citing the period Dr. Høeg spent counseling the FDA commissioner on “medication safety and approval science, including computerized risk analysis and immunization monitoring”.

As acting director, Dr. Høeg inherits the commissioner’s controversial expedited review system, a controversial expedited drug-approval program that reportedly concerned her former heads. “By what process are these medications being selected for this voucher program? Who makes the decisions?” Howard questioned. “There is a lot of confidentiality going on at the FDA right now.”

Overall, he said, “the FDA looks to be trending towards less stringent oversight of all drugs, with the exception of vaccines.”

Documented Track Record on Immunizations

Regarding vaccines, Dr. Høeg has a clearer, if troubling, past, some experts observe. She released a research paper using unconfirmed volunteer-provided data to determine the incidence of myocarditis after Covid immunization. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have changed statistics to indicate Covid vaccinations are more dangerous than they are.

Included in her “desired changes” for the new federal leadership included altering rules for recently developed shots and discontinuing “non-essential” immunizations, she said after the election on a audio program. At the agency, Dr. Høeg has allegedly suggested preventing adolescent males from getting COVID-19 vaccines.

“She’s an thorough ideologue who starts off with her conclusions and tailors the evidence to accommodate the data in a very disingenuous, dishonest way,” Dr. Howard stated.

Consolidating Power and a “Campaign of Retribution”

Høeg became part of fellow skeptics, {like|